` PGNY (Progyny Inc) vs S&P 500 Comparison - Alpha Spread

PGNY
vs
S&P 500

Over the past 12 months, PGNY has underperformed S&P 500, delivering a return of -20% compared to the S&P 500's 12% growth.

Stocks Performance
PGNY vs S&P 500

Loading

Performance Gap
PGNY vs S&P 500

Loading
PGNY
S&P 500
Difference

Performance By Year
PGNY vs S&P 500

Loading
PGNY
S&P 500
Add Stock

Competitors Performance
Progyny Inc vs Peers

Progyny Inc
Glance View

Economic Moat
None
Market Cap
1.9B USD
Industry
Health Care

In a world where the concept of family is continually evolving, Progyny Inc. emerges as a pioneer, reshaping the landscape of fertility and family-building benefits. Founded with a mission to offer comprehensive fertility solutions, the company leverages a unique combination of personalized concierge service and cutting-edge technology to meet the growing demand for reproductive health services. Progyny's role in the industry is substantial, providing a suite of tailored benefits that include fertility treatments, egg freezing, genetic testing, and support services. Through its proprietary Smart Cycle plan, Progyny stands apart by integrating these services into a single, streamlined benefits package, reducing complexities and elevating the experience for patients and employers alike. The heart of Progyny's business model lies in its collaboration with employers, offering them the opportunity to include comprehensive fertility benefits as part of their health packages. By doing so, Progyny opens the door for companies to attract and retain talent in a competitive workforce, ensuring employees have access to vital reproductive assistance. The company generates revenue by partnering with these employers, who pay for the fertility benefits as part of their employee health plans. This innovative approach not only ensures recurring income for Progyny but also aligns the company’s success with positive health outcomes for its clients. As more organizations recognize the value in supporting employees' family-building journeys, Progyny’s influence and relevance in the market continue to grow, reinforcing its standing as a leader in fertility solutions.

PGNY Intrinsic Value
38.42 USD
Undervaluation 42%
Intrinsic Value
Price
Back to Top